November 2014
Grands Prix québecois de la qualité
October 2015
October 2015
Annual Canada Awards for Excellence
Development Programs
Altasciences can provide a customized, end-to-end pathway for your drug development programs, from lead candidate selection through early phase clinical trials. Our platform enables biotechnology and pharmaceutical companies to work with a single, integrated partner to develop molecules through to human proof of concept. Minimizing handoffs throughout the process results in faster timelines and reduced costs.
Our teams of toxicologists, clinical pharmacologists, doctors, bioanalytical principle investigators, and technical staff have a knowledge base that spans a wide range of compounds, study types, therapeutic areas, and routes of administration. We welcome all questions regarding guidance and services you may require to move your compound through the many milestones of early drug development.
Your Altasciences Program Manager will serve as a single point of contact for the entire life of your program, helping your test article advance from one milestone to the next and proactively sharing your preferences across all of our operational groups. Our mantra is: Tell us once…
MOVING YOUR SMALL MOLECULE OR BIOLOGIC TOWARD REGULATORY APPROVAL
The process from lead molecule identification to approval can be long and complicated. Altasciences is here to help streamline and accelerate you through it.
INTEGRATED SERVICES
Preclinical Services
Our Preclinical Services include in vitro and in vivo studies that span lead optimization during discovery to non-clinical studies in rodent and non-rodent species that support drug development through Phase III. We provide a wide range of toxicology and laboratory services that meet global regulatory standards, and are experts at bridging safety assessments for entry into human trials.
Clinical Services
Our Clinical Services span from first-in-human studies to proof-of-concept to all the clinical pharmacology studies required before approval, including supporting studies such as driving simulation and QT assessments. Altasciences is a recognized leader in conducting first-in-human studies in both healthy normal volunteers and patient populations, with both small and large molecules.
Bioanalysis & Research Services
At any point in the process, from discovery through approval, you can rely on our Bioanalysis & Research Services to move your development forward. Our comprehensive full-service model complements our preclinical, nonclinical and clinical offerings to best meet your needs.
THERAPEUTIC AREAS
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.
WHY OUTSOURCE TO ONE PARTNER
Tell us once
Enjoy seamless integration of preclinical and clinical programs managed by ONE program manager.
Reduced timelines
Initiating clinical preparation during the preclinical stage can speed you from one drug development milestone to the next.
Integrated platforms/software
Our systems encompass preclinical and clinical development.
Access to experts
Our scientific and operational specialists deliver input into protocol design, interpretation of findings, and strategic options as you move ahead.
Personalized service
We continuously look for ways to provide value to you.
Quality
Our integrated quality team oversees all services and studies for consistency and thoroughness.
Bioanalytical support
Our Bioanalysis expertise and services encompass your preclinical and clinical needs.
We have your back
Your team at Altasciences believes in transparency, responsiveness, and the importance of being dependable.
Moving in unison, we are the CRO partner who is part of your team.
Altasciences Announces Launch of New Brand and Website
Laval, Quebec, Feb. 12, 2019 – Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development, including preclinical, clinical, bioanalysis, and research services, has unveiled a new brand identity and website. Altasciences’ companies are now further united under the Altasciences brand.
Feedback from our clients and third parties made it clear that our current brand identity did not fully convey the company’s personable and flexible approach, capabilities, expertise and, in particular, the efforts put in to integrating their capabilities and sites with the goal of providing a coordinated approach to early phase development. As a result, Altasciences has aligned its brand with who they are and what they do: Moving in Unison to deliver big impact with a personal touch.
“We’re excited that our new messaging communicates how Altasciences is uniquely positioned to closely partner with sponsors in early drug development and provide the exceptional service our clients have come to expect,” said Julie-Ann Cabana, Vice President of Marketing and Commercial Integration at Altasciences. “The intention of our brand is to reflect the everyday scientific heroes that make drug development a reality. It is about highlighting the importance of partnering with our clients, as well as the human aspect of drug development.”
The brand logo, which has green ribbons moving together in a peak to form an ‘A’, symbolizes the company’s dedication to working together to maintain the highest scientific and operational standards necessary to meet clients’ challenges, while always seeking new opportunities to innovate. Green represents the color of life, growth, harmony, and success. A refreshed graphic approach features imagery that represents real-life moments, demonstrating the vibrancy of life and the essence of what Altasciences does — supporting research that helps bring new medicines to the people who need them, faster. The new identity has been fully rolled out in a revamped company website.
“We’ve spent the past 25 years partnering with our clients to research and develop potentially life-saving therapeutics,” said Chris Perkin, CEO, Altasciences. “Now, our brand identity pays homage to the strength of that heritage. It not only shows who we are as a company, but where we are going.”
About Altasciences
Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.